Literature DB >> 15763752

A review of research on residential programs for people with severe mental illness and co-occurring substance use disorders.

Mary F Brunette1, Kim T Mueser, Robert E Drake.   

Abstract

Substance use disorder is the most common and clinically significant co-morbidity among clients with severe mental illnesses, associated with poor treatment response, homelessness and other adverse outcomes. Residential programs for clients with dual disorders integrate mental health treatment, substance abuse interventions, housing and other supports. Ten controlled studies suggest that greater levels of integration of substance abuse and mental health services are more effective than less integration. Because the research is limited by methodological problems, further research is needed to establish the effectiveness of residential programs, to characterize important program elements, to establish methods to improve engagement into and retention in residential programs and to clarify which clients benefit from this type of service.

Entities:  

Mesh:

Year:  2004        PMID: 15763752     DOI: 10.1080/09595230412331324590

Source DB:  PubMed          Journal:  Drug Alcohol Rev        ISSN: 0959-5236


  48 in total

1.  Long-term sobriety strategies for men with co-occurring disorders.

Authors:  Alison Luciano; Elisabeth L Bryan; Elizabeth A Carpenter-Song; Mary Woods; Katherine Armstrong; Robert E Drake
Journal:  J Dual Diagn       Date:  2014

2.  Consumer and practitioner perceptions of the harm reduction approach in a community mental health setting.

Authors:  Michael A Mancini; Wynter Wyrick-Waugh
Journal:  Community Ment Health J       Date:  2011-10-19

3.  Drug-abusing offenders with comorbid mental disorders: problem severity, treatment participation, and recidivism.

Authors:  Adi Jaffe; Jiang Du; David Huang; Yih-Ing Hser
Journal:  J Subst Abuse Treat       Date:  2012-02-02

4.  Treating homeless clients with severe mental illness and substance use disorders: costs and outcomes.

Authors:  Gary A Morse; Robert J Calsyn; W Dean Klinkenberg; Thomas W Helminiak; Nancy Wolff; Robert E Drake; Robert D Yonker; Gyanesh Lama; Matthew R Lemming; Suzanne McCudden
Journal:  Community Ment Health J       Date:  2006-08-04

Review 5.  Enhancing validity in co-occurring disorders treatment research.

Authors:  Gregory J McHugo; Robert E Drake; Mary F Brunette; Haiyi Xie; Susan M Essock; Alan I Green
Journal:  Schizophr Bull       Date:  2006-07-18       Impact factor: 9.306

6.  The challenge of treating forensic dual diagnosis clients: comment on "integrated treatment for jail recidivists with co-occurring psychiatric and substance use disorders".

Authors:  Robert E Drake; Joseph P Morrissey; Kim T Mueser
Journal:  Community Ment Health J       Date:  2006-08-12

Review 7.  Substance abuse and schizophrenia: pharmacotherapeutic intervention.

Authors:  Alan I Green; Douglas L Noordsy; Mary F Brunette; Christopher O'Keefe
Journal:  J Subst Abuse Treat       Date:  2007-06-15

8.  Management of persons with co-occurring severe mental illness and substance use disorder: program implications.

Authors:  Robert E Drake; Kim T Mueser; Mary F Brunette
Journal:  World Psychiatry       Date:  2007-10       Impact factor: 49.548

9.  Psychometric properties of the Dutch version of the self-sufficiency matrix (SSM-D).

Authors:  Thijs Fassaert; Steve Lauriks; Stef van de Weerd; Jan Theunissen; Martijn Kikkert; Jack Dekker; Marcel Buster; Matty de Wit
Journal:  Community Ment Health J       Date:  2013-12-12

10.  Predicting post-treatment-initiation alcohol use among patients with severe mental illness and alcohol use disorders.

Authors:  Clara M Bradizza; Stephen A Maisto; Paula C Vincent; Paul R Stasiewicz; Gerard J Connors; Nicole D Mercer
Journal:  J Consult Clin Psychol       Date:  2009-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.